 | • レポートコード：MRC2-11QY03014 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はB細胞慢性リンパ球性白血病治療のグローバル市場について調査・分析したレポートです。種類別（AMG-319、ATTCK-20、IDD-002、JNJ-64052781、レナリドマイド、MAT-303、MT-3724、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別B細胞慢性リンパ球性白血病治療の競争状況、市場シェア ・世界のB細胞慢性リンパ球性白血病治療市場：種類別市場規模 2015年-2020年（AMG-319、ATTCK-20、IDD-002、JNJ-64052781、レナリドマイド、MAT-303、MT-3724、その他） ・世界のB細胞慢性リンパ球性白血病治療市場：種類別市場規模予測 2021年-2026年（AMG-319、ATTCK-20、IDD-002、JNJ-64052781、レナリドマイド、MAT-303、MT-3724、その他） ・世界のB細胞慢性リンパ球性白血病治療市場：用途別市場規模 2015年-2020年（クリニック、病院、その他） ・世界のB細胞慢性リンパ球性白血病治療市場：用途別市場規模予測 2021年-2026年（クリニック、病院、その他） ・北米のB細胞慢性リンパ球性白血病治療市場分析：米国、カナダ ・ヨーロッパのB細胞慢性リンパ球性白血病治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのB細胞慢性リンパ球性白血病治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のB細胞慢性リンパ球性白血病治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのB細胞慢性リンパ球性白血病治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AB Science SA、Amgen Inc.、Celgene Corporation、Dynavax Technologies Corporation、Eisai、Elsalys Biotech SAS、F. Hoffmann-La Roche Ltd.、iDD biotech SAS、Immunomedics, Inc.、Johnson & Johnson、Juno Therapeutics Inc.、Molecular Templates Inc.、Noxxon Pharma AG ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global B-Cell Chronic Lymphocytic Leukemia Treatment Market
The global B-Cell Chronic Lymphocytic Leukemia Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global B-Cell Chronic Lymphocytic Leukemia Treatment Scope and Market Size
B-Cell Chronic Lymphocytic Leukemia Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global B-Cell Chronic Lymphocytic Leukemia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the B-Cell Chronic Lymphocytic Leukemia Treatment market is segmented into
AMG-319
ATTCK-20
IDD-002
JNJ-64052781
Lenalidomide
MAT-303
MT-3724
Others
Segment by Application, the B-Cell Chronic Lymphocytic Leukemia Treatment market is segmented into
Clinic
Hospital
Others
Regional and Country-level Analysis
The B-Cell Chronic Lymphocytic Leukemia Treatment market is analysed and market size information is provided by regions (countries).
The key regions covered in the B-Cell Chronic Lymphocytic Leukemia Treatment market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and B-Cell Chronic Lymphocytic Leukemia Treatment Market Share Analysis
B-Cell Chronic Lymphocytic Leukemia Treatment market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in B-Cell Chronic Lymphocytic Leukemia Treatment business, the date to enter into the B-Cell Chronic Lymphocytic Leukemia Treatment market, B-Cell Chronic Lymphocytic Leukemia Treatment product introduction, recent developments, etc.
The major vendors covered:
AB Science SA
Amgen Inc.
Celgene Corporation
Dynavax Technologies Corporation
Eisai
Elsalys Biotech SAS
F. Hoffmann-La Roche Ltd.
iDD biotech SAS
Immunomedics, Inc.
Johnson & Johnson
Juno Therapeutics Inc.
Molecular Templates Inc.
Noxxon Pharma AG
1 Study Coverage
1.1 B-Cell Chronic Lymphocytic Leukemia Treatment Product Introduction
1.2 Market Segments
1.3 Key B-Cell Chronic Lymphocytic Leukemia Treatment Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size Growth Rate by Type
1.4.2 AMG-319
1.4.3 ATTCK-20
1.4.4 IDD-002
1.4.5 JNJ-64052781
1.4.6 Lenalidomide
1.4.7 MAT-303
1.4.8 MT-3724
1.4.9 Others
1.5 Market by Application
1.5.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size Growth Rate by Application
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, Estimates and Forecasts
2.1.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue 2015-2026
2.1.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales 2015-2026
2.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global B-Cell Chronic Lymphocytic Leukemia Treatment Competitor Landscape by Players
3.1 B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Manufacturers
3.1.1 B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Manufacturers (2015-2020)
3.1.2 B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Manufacturers (2015-2020)
3.2 B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Manufacturers
3.2.1 B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Manufacturers (2015-2020)
3.2.2 B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Share by Manufacturers (2015-2020)
3.2.3 Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in 2019
3.2.5 Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 B-Cell Chronic Lymphocytic Leukemia Treatment Price by Manufacturers
3.4 B-Cell Chronic Lymphocytic Leukemia Treatment Manufacturing Base Distribution, Product Types
3.4.1 B-Cell Chronic Lymphocytic Leukemia Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers B-Cell Chronic Lymphocytic Leukemia Treatment Product Type
3.4.3 Date of International Manufacturers Enter into B-Cell Chronic Lymphocytic Leukemia Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Type (2015-2020)
4.1.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Type (2015-2020)
4.1.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Type (2015-2020)
4.1.3 B-Cell Chronic Lymphocytic Leukemia Treatment Average Selling Price (ASP) by Type (2015-2026)
4.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size Forecast by Type (2021-2026)
4.2.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Forecast by Type (2021-2026)
4.2.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Forecast by Type (2021-2026)
4.2.3 B-Cell Chronic Lymphocytic Leukemia Treatment Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Application (2015-2020)
5.1.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Application (2015-2020)
5.1.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Application (2015-2020)
5.1.3 B-Cell Chronic Lymphocytic Leukemia Treatment Price by Application (2015-2020)
5.2 B-Cell Chronic Lymphocytic Leukemia Treatment Market Size Forecast by Application (2021-2026)
5.2.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Forecast by Application (2021-2026)
5.2.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Forecast by Application (2021-2026)
5.2.3 Global B-Cell Chronic Lymphocytic Leukemia Treatment Price Forecast by Application (2021-2026)
6 North America
6.1 North America B-Cell Chronic Lymphocytic Leukemia Treatment by Country
6.1.1 North America B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Country
6.1.2 North America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America B-Cell Chronic Lymphocytic Leukemia Treatment Market Facts & Figures by Type
6.3 North America B-Cell Chronic Lymphocytic Leukemia Treatment Market Facts & Figures by Application
7 Europe
7.1 Europe B-Cell Chronic Lymphocytic Leukemia Treatment by Country
7.1.1 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Country
7.1.2 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Facts & Figures by Type
7.3 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific B-Cell Chronic Lymphocytic Leukemia Treatment by Region
8.1.1 Asia Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Region
8.1.2 Asia Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Market Facts & Figures by Type
8.3 Asia Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Market Facts & Figures by Application
9 Latin America
9.1 Latin America B-Cell Chronic Lymphocytic Leukemia Treatment by Country
9.1.1 Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Country
9.1.2 Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America B-Cell Chronic Lymphocytic Leukemia Treatment Market Facts & Figures by Type
9.3 Central & South America B-Cell Chronic Lymphocytic Leukemia Treatment Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa B-Cell Chronic Lymphocytic Leukemia Treatment by Country
10.1.1 Middle East and Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Country
10.1.2 Middle East and Africa B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa B-Cell Chronic Lymphocytic Leukemia Treatment Market Facts & Figures by Type
10.3 Middle East and Africa B-Cell Chronic Lymphocytic Leukemia Treatment Market Facts & Figures by Application
11 Company Profiles
11.1 AB Science SA
11.1.1 AB Science SA Corporation Information
11.1.2 AB Science SA Description and Business Overview
11.1.3 AB Science SA Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Products Offered
11.1.5 AB Science SA Related Developments
11.2 Amgen Inc.
11.2.1 Amgen Inc. Corporation Information
11.2.2 Amgen Inc. Description and Business Overview
11.2.3 Amgen Inc. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Products Offered
11.2.5 Amgen Inc. Related Developments
11.3 Celgene Corporation
11.3.1 Celgene Corporation Corporation Information
11.3.2 Celgene Corporation Description and Business Overview
11.3.3 Celgene Corporation Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Products Offered
11.3.5 Celgene Corporation Related Developments
11.4 Dynavax Technologies Corporation
11.4.1 Dynavax Technologies Corporation Corporation Information
11.4.2 Dynavax Technologies Corporation Description and Business Overview
11.4.3 Dynavax Technologies Corporation Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Products Offered
11.4.5 Dynavax Technologies Corporation Related Developments
11.5 Eisai
11.5.1 Eisai Corporation Information
11.5.2 Eisai Description and Business Overview
11.5.3 Eisai Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Products Offered
11.5.5 Eisai Related Developments
11.6 Elsalys Biotech SAS
11.6.1 Elsalys Biotech SAS Corporation Information
11.6.2 Elsalys Biotech SAS Description and Business Overview
11.6.3 Elsalys Biotech SAS Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Products Offered
11.6.5 Elsalys Biotech SAS Related Developments
11.7 F. Hoffmann-La Roche Ltd.
11.7.1 F. Hoffmann-La Roche Ltd. Corporation Information
11.7.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
11.7.3 F. Hoffmann-La Roche Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Products Offered
11.7.5 F. Hoffmann-La Roche Ltd. Related Developments
11.8 iDD biotech SAS
11.8.1 iDD biotech SAS Corporation Information
11.8.2 iDD biotech SAS Description and Business Overview
11.8.3 iDD biotech SAS Sales, Revenue and Gross Margin (2015-2020)
11.8.4 iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Products Offered
11.8.5 iDD biotech SAS Related Developments
11.9 Immunomedics, Inc.
11.9.1 Immunomedics, Inc. Corporation Information
11.9.2 Immunomedics, Inc. Description and Business Overview
11.9.3 Immunomedics, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Products Offered
11.9.5 Immunomedics, Inc. Related Developments
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Corporation Information
11.10.2 Johnson & Johnson Description and Business Overview
11.10.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Products Offered
11.10.5 Johnson & Johnson Related Developments
11.1 AB Science SA
11.1.1 AB Science SA Corporation Information
11.1.2 AB Science SA Description and Business Overview
11.1.3 AB Science SA Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Products Offered
11.1.5 AB Science SA Related Developments
11.12 Molecular Templates Inc.
11.12.1 Molecular Templates Inc. Corporation Information
11.12.2 Molecular Templates Inc. Description and Business Overview
11.12.3 Molecular Templates Inc. Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Molecular Templates Inc. Products Offered
11.12.5 Molecular Templates Inc. Related Developments
11.13 Noxxon Pharma AG
11.13.1 Noxxon Pharma AG Corporation Information
11.13.2 Noxxon Pharma AG Description and Business Overview
11.13.3 Noxxon Pharma AG Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Noxxon Pharma AG Products Offered
11.13.5 Noxxon Pharma AG Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 B-Cell Chronic Lymphocytic Leukemia Treatment Market Estimates and Projections by Region
12.1.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Forecast by Regions 2021-2026
12.1.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Forecast by Regions 2021-2026
12.2 North America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size Forecast (2021-2026)
12.2.1 North America: B-Cell Chronic Lymphocytic Leukemia Treatment Sales Forecast (2021-2026)
12.2.2 North America: B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Forecast (2021-2026)
12.2.3 North America: B-Cell Chronic Lymphocytic Leukemia Treatment Market Size Forecast by Country (2021-2026)
12.3 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Size Forecast (2021-2026)
12.3.1 Europe: B-Cell Chronic Lymphocytic Leukemia Treatment Sales Forecast (2021-2026)
12.3.2 Europe: B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Forecast (2021-2026)
12.3.3 Europe: B-Cell Chronic Lymphocytic Leukemia Treatment Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: B-Cell Chronic Lymphocytic Leukemia Treatment Sales Forecast (2021-2026)
12.4.2 Asia Pacific: B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: B-Cell Chronic Lymphocytic Leukemia Treatment Market Size Forecast by Region (2021-2026)
12.5 Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size Forecast (2021-2026)
12.5.1 Latin America: B-Cell Chronic Lymphocytic Leukemia Treatment Sales Forecast (2021-2026)
12.5.2 Latin America: B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Forecast (2021-2026)
12.5.3 Latin America: B-Cell Chronic Lymphocytic Leukemia Treatment Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa B-Cell Chronic Lymphocytic Leukemia Treatment Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: B-Cell Chronic Lymphocytic Leukemia Treatment Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: B-Cell Chronic Lymphocytic Leukemia Treatment Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key B-Cell Chronic Lymphocytic Leukemia Treatment Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 B-Cell Chronic Lymphocytic Leukemia Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. B-Cell Chronic Lymphocytic Leukemia Treatment Market Segments
Table 2. Ranking of Global Top B-Cell Chronic Lymphocytic Leukemia Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of AMG-319
Table 5. Major Manufacturers of ATTCK-20
Table 6. Major Manufacturers of IDD-002
Table 7. Major Manufacturers of JNJ-64052781
Table 8. Major Manufacturers of Lenalidomide
Table 9. Major Manufacturers of MAT-303
Table 10. Major Manufacturers of MT-3724
Table 11. Major Manufacturers of Others
Table 12. Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 13. Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 14. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Regions 2015-2020 (K Pcs)
Table 15. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Regions (2015-2020)
Table 16. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Manufacturers (2015-2020) (K Pcs)
Table 18. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Share by Manufacturers (2015-2020)
Table 19. Global B-Cell Chronic Lymphocytic Leukemia Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global B-Cell Chronic Lymphocytic Leukemia Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in B-Cell Chronic Lymphocytic Leukemia Treatment as of 2019)
Table 21. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers B-Cell Chronic Lymphocytic Leukemia Treatment Price (2015-2020) (USD/Pcs)
Table 24. B-Cell Chronic Lymphocytic Leukemia Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers B-Cell Chronic Lymphocytic Leukemia Treatment Product Type
Table 26. Date of International Manufacturers Enter into B-Cell Chronic Lymphocytic Leukemia Treatment Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Type (2015-2020) (K Pcs)
Table 29. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Share by Type (2015-2020)
Table 30. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Type (2015-2020) (US$ Million)
Table 31. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Share by Type (2015-2020)
Table 32. B-Cell Chronic Lymphocytic Leukemia Treatment Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 33. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Application (2015-2020) (K Pcs)
Table 34. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Share by Application (2015-2020)
Table 35. North America B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Country (2015-2020) (K Pcs)
Table 36. North America B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Country (2015-2020)
Table 37. North America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Country (2015-2020) (US$ Million)
Table 38. North America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Country (2015-2020)
Table 39. North America B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Type (2015-2020) (K Pcs)
Table 40. North America B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Type (2015-2020)
Table 41. North America B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Application (2015-2020) (K Pcs)
Table 42. North America B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Application (2015-2020)
Table 43. Europe B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Country (2015-2020) (K Pcs)
Table 44. Europe B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Country (2015-2020)
Table 45. Europe B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Country (2015-2020)
Table 47. Europe B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Type (2015-2020) (K Pcs)
Table 48. Europe B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Type (2015-2020)
Table 49. Europe B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Application (2015-2020) (K Pcs)
Table 50. Europe B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Region (2015-2020) (K Pcs)
Table 52. Asia Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Type (2015-2020) (K Pcs)
Table 56. Asia Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Application (2015-2020) (K Pcs)
Table 58. Asia Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Application (2015-2020)
Table 59. Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Country (2015-2020) (K Pcs)
Table 60. Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Country (2015-2020)
Table 63. Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Type (2015-2020) (K Pcs)
Table 64. Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Type (2015-2020)
Table 65. Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Application (2015-2020) (K Pcs)
Table 66. Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Country (2015-2020) (K Pcs)
Table 68. Middle East and Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Type (2015-2020) (K Pcs)
Table 72. Middle East and Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Application (2015-2020) (K Pcs)
Table 74. Middle East and Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Application (2015-2020)
Table 75. AB Science SA Corporation Information
Table 76. AB Science SA Description and Major Businesses
Table 77. AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. AB Science SA Product
Table 79. AB Science SA Recent Development
Table 80. Amgen Inc. Corporation Information
Table 81. Amgen Inc. Description and Major Businesses
Table 82. Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Amgen Inc. Product
Table 84. Amgen Inc. Recent Development
Table 85. Celgene Corporation Corporation Information
Table 86. Celgene Corporation Description and Major Businesses
Table 87. Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Celgene Corporation Product
Table 89. Celgene Corporation Recent Development
Table 90. Dynavax Technologies Corporation Corporation Information
Table 91. Dynavax Technologies Corporation Description and Major Businesses
Table 92. Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Dynavax Technologies Corporation Product
Table 94. Dynavax Technologies Corporation Recent Development
Table 95. Eisai Corporation Information
Table 96. Eisai Description and Major Businesses
Table 97. Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Eisai Product
Table 99. Eisai Recent Development
Table 100. Elsalys Biotech SAS Corporation Information
Table 101. Elsalys Biotech SAS Description and Major Businesses
Table 102. Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Elsalys Biotech SAS Product
Table 104. Elsalys Biotech SAS Recent Development
Table 105. F. Hoffmann-La Roche Ltd. Corporation Information
Table 106. F. Hoffmann-La Roche Ltd. Description and Major Businesses
Table 107. F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. F. Hoffmann-La Roche Ltd. Product
Table 109. F. Hoffmann-La Roche Ltd. Recent Development
Table 110. iDD biotech SAS Corporation Information
Table 111. iDD biotech SAS Description and Major Businesses
Table 112. iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 113. iDD biotech SAS Product
Table 114. iDD biotech SAS Recent Development
Table 115. Immunomedics, Inc. Corporation Information
Table 116. Immunomedics, Inc. Description and Major Businesses
Table 117. Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 118. Immunomedics, Inc. Product
Table 119. Immunomedics, Inc. Recent Development
Table 120. Johnson & Johnson Corporation Information
Table 121. Johnson & Johnson Description and Major Businesses
Table 122. Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. Johnson & Johnson Product
Table 124. Johnson & Johnson Recent Development
Table 125. Juno Therapeutics Inc. Corporation Information
Table 126. Juno Therapeutics Inc. Description and Major Businesses
Table 127. Juno Therapeutics Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. Juno Therapeutics Inc. Product
Table 129. Juno Therapeutics Inc. Recent Development
Table 130. Molecular Templates Inc. Corporation Information
Table 131. Molecular Templates Inc. Description and Major Businesses
Table 132. Molecular Templates Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 133. Molecular Templates Inc. Product
Table 134. Molecular Templates Inc. Recent Development
Table 135. Noxxon Pharma AG Corporation Information
Table 136. Noxxon Pharma AG Description and Major Businesses
Table 137. Noxxon Pharma AG B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 138. Noxxon Pharma AG Product
Table 139. Noxxon Pharma AG Recent Development
Table 140. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Forecast by Regions (2021-2026) (K Pcs)
Table 141. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share Forecast by Regions (2021-2026)
Table 142. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 143. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share Forecast by Regions (2021-2026)
Table 144. North America: B-Cell Chronic Lymphocytic Leukemia Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 145. North America: B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Europe: B-Cell Chronic Lymphocytic Leukemia Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 147. Europe: B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Asia Pacific: B-Cell Chronic Lymphocytic Leukemia Treatment Sales Forecast by Region (2021-2026) (K Pcs)
Table 149. Asia Pacific: B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Forecast by Region (2021-2026) (US$ Million)
Table 150. Latin America: B-Cell Chronic Lymphocytic Leukemia Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 151. Latin America: B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 152. Middle East and Africa: B-Cell Chronic Lymphocytic Leukemia Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 153. Middle East and Africa: B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 154. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 155. Key Challenges
Table 156. Market Risks
Table 157. Main Points Interviewed from Key B-Cell Chronic Lymphocytic Leukemia Treatment Players
Table 158. B-Cell Chronic Lymphocytic Leukemia Treatment Customers List
Table 159. B-Cell Chronic Lymphocytic Leukemia Treatment Distributors List
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. B-Cell Chronic Lymphocytic Leukemia Treatment Product Picture
Figure 2. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Type in 2020 & 2026
Figure 3. AMG-319 Product Picture
Figure 4. ATTCK-20 Product Picture
Figure 5. IDD-002 Product Picture
Figure 6. JNJ-64052781 Product Picture
Figure 7. Lenalidomide Product Picture
Figure 8. MAT-303 Product Picture
Figure 9. MT-3724 Product Picture
Figure 10. Others Product Picture
Figure 11. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Application in 2020 & 2026
Figure 12. Clinic
Figure 13. Hospital
Figure 14. Others
Figure 15. B-Cell Chronic Lymphocytic Leukemia Treatment Report Years Considered
Figure 16. Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size 2015-2026 (US$ Million)
Figure 17. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales 2015-2026 (K Pcs)
Figure 18. Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Region (2015-2020)
Figure 20. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Region in 2019
Figure 21. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Region (2015-2020)
Figure 22. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Region in 2019
Figure 23. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Share by Manufacturer in 2019
Figure 24. The Top 10 and 5 Players Market Share by B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in 2019
Figure 25. B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 26. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Type (2015-2020)
Figure 27. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Type in 2019
Figure 28. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Type (2015-2020)
Figure 29. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Type in 2019
Figure 30. Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Price Range (2015-2020)
Figure 31. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Application (2015-2020)
Figure 32. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Application in 2019
Figure 33. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Application (2015-2020)
Figure 34. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Application in 2019
Figure 35. North America B-Cell Chronic Lymphocytic Leukemia Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 36. North America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 37. North America B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Country in 2019
Figure 38. North America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Country in 2019
Figure 39. U.S. B-Cell Chronic Lymphocytic Leukemia Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. U.S. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Canada B-Cell Chronic Lymphocytic Leukemia Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 42. Canada B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. North America B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Type in 2019
Figure 44. North America B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Application in 2019
Figure 45. Europe B-Cell Chronic Lymphocytic Leukemia Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 46. Europe B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Country in 2019
Figure 48. Europe B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Country in 2019
Figure 49. Germany B-Cell Chronic Lymphocytic Leukemia Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. Germany B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France B-Cell Chronic Lymphocytic Leukemia Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. France B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. B-Cell Chronic Lymphocytic Leukemia Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. U.K. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy B-Cell Chronic Lymphocytic Leukemia Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Italy B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia B-Cell Chronic Lymphocytic Leukemia Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 58. Russia B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Type in 2019
Figure 60. Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Application in 2019
Figure 61. Asia Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 62. Asia Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Region in 2019
Figure 64. Asia Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Region in 2019
Figure 65. China B-Cell Chronic Lymphocytic Leukemia Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. China B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan B-Cell Chronic Lymphocytic Leukemia Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea B-Cell Chronic Lymphocytic Leukemia Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. South Korea B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India B-Cell Chronic Lymphocytic Leukemia Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. India B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia B-Cell Chronic Lymphocytic Leukemia Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Australia B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan B-Cell Chronic Lymphocytic Leukemia Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Taiwan B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia B-Cell Chronic Lymphocytic Leukemia Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Indonesia B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand B-Cell Chronic Lymphocytic Leukemia Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Thailand B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia B-Cell Chronic Lymphocytic Leukemia Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Malaysia B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines B-Cell Chronic Lymphocytic Leukemia Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Philippines B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam B-Cell Chronic Lymphocytic Leukemia Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 86. Vietnam B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Asia Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Type in 2019
Figure 88. Asia Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Application in 2019
Figure 89. Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 90. Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Country in 2019
Figure 92. Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Country in 2019
Figure 93. Mexico B-Cell Chronic Lymphocytic Leukemia Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Mexico B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil B-Cell Chronic Lymphocytic Leukemia Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Brazil B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina B-Cell Chronic Lymphocytic Leukemia Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 98. Argentina B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Type in 2019
Figure 100. Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Application in 2019
Figure 101. Middle East and Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 102. Middle East and Africa B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 103. Middle East and Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Country in 2019
Figure 104. Middle East and Africa B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Country in 2019
Figure 105. Turkey B-Cell Chronic Lymphocytic Leukemia Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Turkey B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Saudi Arabia B-Cell Chronic Lymphocytic Leukemia Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. Saudi Arabia B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. U.A.E B-Cell Chronic Lymphocytic Leukemia Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 110. U.A.E B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 111. Middle East and Africa B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Type in 2019
Figure 112. Middle East and Africa B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Application in 2019
Figure 113. North America B-Cell Chronic Lymphocytic Leukemia Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. North America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe B-Cell Chronic Lymphocytic Leukemia Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Europe B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Asia Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 122. Middle East and Africa B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed
慢性リンパ性白血病（CLL）治療の世界市場（～2026年） Accumulation of functionally incompetent monocytes is referred as Chronic Lymphocytic Leukemia (CLL). Chronic Lymphocytic Leukemia is a type of monoclonal disorder and is commonly found in adults in western countries. Based on the severity, patients diagnosed with chronic lymphocytic leukemia die wi…- 慢性リンパ性白血病（CLL）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Chronic Lymphocytic Leukemia Therapeutics Market The global Chronic Lymphocytic Leukemia Therapeutics market size is projected to reach US$ 9390.9 million by 2026, from US$ 8411.2 million in 2020, at a CAGR of 10.8%% during 2021-2026. Global Chronic Lymphocytic L…
- 慢性骨髄性白血病治療の世界市場（～2026年） Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. It's a type of cancer that starts in certain blood-forming cells of the bone marrow. Market Analysis and Insights: Global Chronic Myelogenous Leukemia Treatment Market The global Chronic Myelogenous Leukemia Treatment mark…
- 有毛細胞白血病治療の世界市場（～2026年） Hairy cell leukemia is a rare type of cancer of blood which is caused due to abnormal growth of B cells. It has been observed that out of all the leukemia’s, hairy cell leukemia accounts for about 2% and thus eventually must be treated after its prominent symptoms. The drivers for the HCL market can…
- 成人T細胞白血病/リンパ腫治療の世界市場（～2026年） Adult T-cell lymphoma/leukemia (ATL) is a rare T-cell lymphoproliferative neoplasm caused by human T-lymphotrophic virus 1. In its more common, aggressive forms, ATL carries one of the poorest prognoses of the non-Hodgkin lymphomas. The disease has clinical subtypes (ie, acute, lymphoma, chronic, an…